FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992460147> ?p ?o ?g. }

• W1992460147 endingPage "311" @default.
• W1992460147 startingPage "311" @default.
• W1992460147 abstract "<h2>Abstract</h2> <b>Introduction.</b> The branched-chain amino acids, particularly leucine, appear to activate protein synthesis in skeletal muscle by a signal transduction pathway involving the protein kinase mTOR (mammalian target of rapamycin). While leucine also inhibits proteolysis in skeletal muscle, the mechanism for this action is poorly understood. Recently it has been found that another important anabolic factor for muscle, insulin, inhibits proteolysis in this tissue by sequential activation of a nutrient-sensing pathway requiring PI3K (phosphatidylinositol 3-kinase), Akt kinase, and mTOR. We studied the role of these kinases in mediating the effects of leucine on protein breakdown, and whether leucine or its metabolites are the critical signal for inhibition of proteolysis. <b>Methods.</b> L6 myotubes (a rat skeletal muscle cell line) were incubated with leucine (5 mM) in the presence or absence of wortmannin or rapamycin (100 nM each), inhibitors of PI3K and mTOR, respectively. Rates of protein degradation were measured by the release of acid-soluble ³H-tyrosine from pre-labeled muscle protein. Statistical analysis was performed using one-way ANOVA. <b>Results.</b> Leucine caused a significant reduction in proteolysis compared to controls (−8 to 12%, <i>P</i> < 0.001). This effect of leucine was not influenced by wortmannin. Conversely, rapamycin completely blocked the ability of leucine to inhibit proteolysis. Furthermore (data not shown), the transamination product of leucine, α-KIC (ketoisocaproic acid), was equally if not more effective in inhibiting proteolysis in the myotubes than leucine itself (up to 20% inhibition). <b>Conclusions.</b> Leucine or its metabolites appear to inhibit skeletal muscle proteolysis by activation of mTOR signaling, but unlike the known effects of insulin on this process, the upstream kinase PI3K is not required. TABLE—ABSTRACT P16Effect of Leucine on Proteolysis in Myotubes (%/24hrs)Control+ Leucine+Leucine +Wortmannin+Leucine +Rapamycin29.6 ± 0.527.2 ± 0.426.7 ± 0.4∗31.2 ± 0.3<i>Note.</i> Shown are means ± SEM; n=6;∗P < 0.001 versus Control." @default.
• W1992460147 created "2016-06-24" @default.
• W1992460147 creator A5004372581 @default.
• W1992460147 creator A5024291036 @default.
• W1992460147 creator A5091364965 @default.
• W1992460147 date "2004-10-01" @default.
• W1992460147 modified "2023-09-24" @default.
• W1992460147 title "Leucine inhibits proteolysis by the mTOR kinase signaling pathway in skeletal muscle" @default.
• W1992460147 doi "https://doi.org/10.1016/j.jss.2004.07.145" @default.
• W1992460147 hasPublicationYear "2004" @default.
• W1992460147 type Work @default.
• W1992460147 sameAs 1992460147 @default.
• W1992460147 citedByCount "8" @default.
• W1992460147 countsByYear W19924601472012 @default.
• W1992460147 countsByYear W19924601472015 @default.
• W1992460147 countsByYear W19924601472017 @default.
• W1992460147 countsByYear W19924601472019 @default.
• W1992460147 countsByYear W19924601472022 @default.
• W1992460147 crossrefType "journal-article" @default.
• W1992460147 hasAuthorship W1992460147A5004372581 @default.
• W1992460147 hasAuthorship W1992460147A5024291036 @default.
• W1992460147 hasAuthorship W1992460147A5091364965 @default.
• W1992460147 hasConcept C11960822 @default.
• W1992460147 hasConcept C134018914 @default.
• W1992460147 hasConcept C181199279 @default.
• W1992460147 hasConcept C2776580952 @default.
• W1992460147 hasConcept C2778308172 @default.
• W1992460147 hasConcept C2779959927 @default.
• W1992460147 hasConcept C2781307694 @default.
• W1992460147 hasConcept C3763915 @default.
• W1992460147 hasConcept C515207424 @default.
• W1992460147 hasConcept C55493867 @default.
• W1992460147 hasConcept C62478195 @default.
• W1992460147 hasConcept C75217442 @default.
• W1992460147 hasConcept C86554907 @default.
• W1992460147 hasConcept C86803240 @default.
• W1992460147 hasConcept C95444343 @default.
• W1992460147 hasConceptScore W1992460147C11960822 @default.
• W1992460147 hasConceptScore W1992460147C134018914 @default.
• W1992460147 hasConceptScore W1992460147C181199279 @default.
• W1992460147 hasConceptScore W1992460147C2776580952 @default.
• W1992460147 hasConceptScore W1992460147C2778308172 @default.
• W1992460147 hasConceptScore W1992460147C2779959927 @default.
• W1992460147 hasConceptScore W1992460147C2781307694 @default.
• W1992460147 hasConceptScore W1992460147C3763915 @default.
• W1992460147 hasConceptScore W1992460147C515207424 @default.
• W1992460147 hasConceptScore W1992460147C55493867 @default.
• W1992460147 hasConceptScore W1992460147C62478195 @default.
• W1992460147 hasConceptScore W1992460147C75217442 @default.
• W1992460147 hasConceptScore W1992460147C86554907 @default.
• W1992460147 hasConceptScore W1992460147C86803240 @default.
• W1992460147 hasConceptScore W1992460147C95444343 @default.
• W1992460147 hasIssue "2" @default.
• W1992460147 hasLocation W19924601471 @default.
• W1992460147 hasOpenAccess W1992460147 @default.
• W1992460147 hasPrimaryLocation W19924601471 @default.
• W1992460147 hasRelatedWork W1968663121 @default.
• W1992460147 hasRelatedWork W2013128540 @default.
• W1992460147 hasRelatedWork W2031149309 @default.
• W1992460147 hasRelatedWork W2041560048 @default.
• W1992460147 hasRelatedWork W2050167066 @default.
• W1992460147 hasRelatedWork W2113017107 @default.
• W1992460147 hasRelatedWork W2150080176 @default.
• W1992460147 hasRelatedWork W2169526798 @default.
• W1992460147 hasRelatedWork W2392649720 @default.
• W1992460147 hasRelatedWork W2512713470 @default.
• W1992460147 hasVolume "121" @default.
• W1992460147 isParatext "false" @default.
• W1992460147 isRetracted "false" @default.
• W1992460147 magId "1992460147" @default.
• W1992460147 workType "article" @default.